Aligos Therapeutics, Inc 10-K for FY2025
Aligos Therapeutics, Inc. (ALGS)
10-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
Aligos Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.19M
- down 39.5% from $3.61M a year earlier
- Net loss
- $24.19M
- compared with a net loss of $131.21M a year earlier
- Diluted EPS
- -$2.45
- compared with -$20.94 a year earlier